Indicators
Indicators
Value
Direction
MACD(12,26,9)
-2.123
Sell
RSI(14)
45.078
Neutral
STOCH(KDJ)(9,3,3)
21.120
Neutral
ATR(14)
6.023
High Vlolatility
CCI(14)
-71.822
Neutral
Williams %R
69.000
Sell
TRIX(12,20)
-0.140
Sell
StochRSI(14)
97.564
Buy
Ascendis Pharma A/S
ASNDView Detailed Chart
166.780USD
+3.460+2.12%
Close 07/30, 16:00（ET）Quotes delayed by 15 min
10.17BMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+2.12%
5 Days
-1.97%
1 Month
-3.37%
6 Months
+31.01%
Year to Date
+21.14%
1 Year
+24.52%
View Detailed Chart
Agency Rating
Analyst Rating
Based on
17
analysts
BUY
Current Rating
232.625
Target Price
42.44%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
553
Total
5
Median
6
Average
Company name
Ratings
Analysts
Ascendis Pharma A/S
ASND
17
CRISPR Therapeutics AG
CRSP
29
Intellia Therapeutics Inc
NTLA
28
Exact Sciences Corp
EXAS
27
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
1
2
3
...
111
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Neutral
Moving Average
Indicators
Value
Direction
MA5
166.008
Buy
MA10
168.084
Sell
MA20
171.223
Sell
MA50
170.373
Sell
MA100
163.650
Buy
MA200
148.518
Buy
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
Ticker SymbolASND
CompanyAscendis Pharma A/S
CEOMr. Jan Moller Mikkelsen
Websitehttps://ascendispharma.dk/
Related Instruments
-0.03%
+0.02%
-1.55%
-1.90%
-1.28%
-0.30%
+0.17%
-2.00%
-2.26%
-0.98%
-0.82%
-0.23%
-0.28%
-2.91%
-1.56%
-1.27%
+0.14%
-0.88%
+3.89%
+4.56%
